Los Angeles Times The makers of the proposed weight-loss drug Contrave said this week they have taken a key first step in showing that the medication does not boost the heart and stroke risks of those taking it.
http://readingeagle.com/article.aspx?id=520527
http://readingeagle.com/article.aspx?id=520527
No comments:
Post a Comment